Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.

Gupta S, Kumari S. Anais brasileiros de dermatologia. 2021;
Download PDF
Publication

Quali-quantitative synthesis of the global scenario of patent families about leprosy.

Meneghin R. Ciencia & saude coletiva. 2021; 26 (11) : 5411-5426.
Download PDF
Publication

Leprosy Masquerading as Tinea Faciale

Daroach M, Bhallavi H, Narang T. Georg Thieme Verlag KG. Annals of the National Academy of Medical Sciences (India). 2021;
Download PDF
Publication

Blame-game politics: Re-evaluating incongruent leprosy and COVID-19 policies in the Old Testament and Nigerian societies

Agbo PO, Okwueze M, Okoye K, et al. AOSIS. Verbum et Ecclesia. 2021;
Download PDF
Publication

The Phenomenology Study of Phenomenology: Experience of Self-Caring of Leprosy Patients in the Central Medicine and Disabled St. Damian Cancar, Manggarai

Simon M, Wea L, Mariaty L. EAI. Proceedings of the 1st International Conference on Education, Humanities, Health and Agriculture, ICEHHA 2021, 3-4 June 2021, Ruteng, Flores, Indonesia. 2021;
Download PDF
Publication

Risk Factors of Type 1 Leprosy Reaction in Leprosy Patients attending Leprosy Division of Dermatology and Venereology Outpatient Clinic of Dr Soetomo General Hospital in 2017–2019: A Retrospective Study

Rosdiana B, Astari L, Astindari A, et al. Scientific Foundation SPIROSKI. Open Access Macedonian Journal of Medical Sciences. 2021; 9 (B) : 1359-1363.
Download PDF
Publication

O manejo da hanseníase em tempos de pandemia

Lacerda GCES, Ferraz MDGC, Alencar MDAX, et al. Atena Editora. Doenças infectocontagiosas e o controle de infecção hospitalar: Desafios em tempos de pandemia. 2021;
Download PDF
Publication

The Perception of Leprosy. Studies on assessment, impact and interventions at individual, family and community level.

van 't Noordende A. Erasmus University Rotterdam. 2021;
Download PDF
Publication

Clinical, Neurophysiological and Histopatological correlations in Pure Neural Leprosy

Pitta IJR, Mietto BDS, Camilo ADS, et al. Publicacoes Cientificas de Acesso Aberto e Editora LTDA. Brazilian Journal of Case Reports. 2021; 1 (4) : 105-113.
Download PDF
Publication

Case Detection Delay Questionnaire

De Bruijne ND, Urgesa K, Aseffa A, et al. PLoS neglected tropical diseases. 2022;

Pagination

  • Previous page ‹‹
  • Page 234
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD